Faculty Mentors Guide Aspiring Researchers from Mexico in Program – University of Texas at Dallas (press release)

Text size: campus

Sept. 7, 2017

Fifteen undergraduates participated in a summer program at The University of Texas at Dallas that invites students from Mexico to explore STEM-related research careers in fields such as biology, geographic information systems, materials science, physics, computer science and bioengineering.

The UT Dallas-Mexico Summer Research Program is designed to equip students from participating Mexican universities with the skills and knowledge needed to pursue careers in these fields.

Through the program, students work with faculty mentors to identify and manage a research project, then analyze the data and present their findings. Students were competitively selected from more than 240 applicants.

UT Dallas-MexicoSummer Faculty Mentors

Dr. Zachary Campbell, Dr. Michael C. Biewer, Dr. Vibhav Gogate, Dr. Kelli Palmer, Dr. Murat Kantarcioglu, Dr. Fan Zhang, Dr. Nicholas Fey, Dr. Robert Gregg, Dr. Julia Chan, Dr. Vincent Ng, Dr. Ronald A. Smaldone, Dr. Xiaohu Guo, Dr. Julia Hsu, Dr. Dinesh K. Bhatia, Thomas Lambert

Dr. Juan Gonzlez, professor of biological sciences in the School of Natural Sciences and Mathematics and the programs academic director, said participants gain enhanced knowledge and experience with research careers.

One of our goals is to provide the students with experiences that will better inform them on the rewards of a future research career and inspire them to pursue a higher degree in one of the STEM fields, Gonzlez said. We also hope to enhance further the collaboration between the research communities of both Mexico and the U.S.

The program, which has existed for 13 years, was organized by the Office of Graduate Studies, the Provosts Office and the International Center, with the co-sponsorship of the School of Natural Sciences and Mathematics, the School of Arts and Humanities and the Office of Undergraduate Education. Since 2002, 139 undergraduate students have taken part in the UT Dallas program.

The program is made possible through a partnership with 100,000 Strong in the Americas and the U.S.-Mexico Bilateral Forum on Higher Education, Innovation, and Research.

Dr. Julia W.P. Hsu, Texas Instruments Distinguished Chair in Nanoelectronics and professor of materials science in the Erik Jonsson School of Engineering and Computer Science, described program participant Laura Yoselyn Quiroga as an enthusiastic and eager young scientist.

She is talented and ambitious, and has done a lot of reading. She is not afraid of getting her hands dirty and doing hard work. Her performance this summer strongly suggests that she will be successful in graduate school. As a mentor, it is very gratifying to see her flourish during the short time at UT Dallas, Hsu said.

Summer Research Participants

Adzuira Musule Palacios, Christopher Jquez Prado, Sandra Berenice Mendoza Peuuri,Zayd Alejandro Grajales Moreno,Juan Maldonado Juregui,Miriam Yamasaki Aguilar, Daniel Ayala Nio, Jonathan Martnez Garca, Jos Gonzlez Ayerdi, SwilmaLabastida, Laura Yoselyn Quiroga Lpez, Irving Osiel Castillo Rodriguez, Noor Beatriz Tuma Schmidt, Anaid Alethia Candido Lopez, Gerardo Ocampo Daz

Dr. Nicholas Fey, assistant professor of bioengineering and mechanical engineering, praised the creative ideas that participantSwilma Labastida brought to her summer research project.

Swilma operated with incredible maturity and independence for a researcher of her age. We are excited to submit the findings from her scientific studies for publication at an international conference and in a biomechanical engineering journal this fall. I hope she considers graduate studies in engineering and that she applies to UT Dallas, Fey said.

Computer science student Christopher Jquez Prado said he appreciated the collaborative interaction with his mentor, Dr. Murat Kantarcioglu.

I initially expected some sort of boss-employee scenario, but to my surprise and enjoyment we've been working together in a cooperative way, Prado said.

Francisco de la Torre, Consul General of Mexico in Dallas, said partnerships like the summer research program benefits both Mexico and the U.S.

This academic cooperation, where UT Dallas excels as a leader in Texas, is helping expand opportunities for educational exchanges, scientific research partnerships and cross-border innovation so we can continue building bridges for mutual economic prosperity and sustainable social development, de la Torre said.

Media Contact: Robin Russell, UT Dallas, (972) 883-4431, [emailprotected]or the Office of Media Relations, UT Dallas, (972) 883-2155, [emailprotected].

Read the original post:
Faculty Mentors Guide Aspiring Researchers from Mexico in Program - University of Texas at Dallas (press release)

HealthWatch: Predicting Preemies: Building Healthier Babies – WeAreGreenBay.com

PALO ALTO, Calif. (Ivanhoe Newswire) The tiniest of tiny, preemies, weighing in at three, two, even one pound are being born, surviving and thriving. The youngest baby to survive was born at just 21 weeks.

Baby James is now in his mid-20s and perfectly healthy. Any baby born before 37 weeks is considered premature. Right now, theres no telling which moms will deliver early and which ones will go the full 40 weeks. But soon a simple blood test may be able to pinpoint a due date and save little lives.

You could say Haven and his mom are both heroes.

Havens mother Amanda Smith said, I tell people this is like a war zone, only this time its not my life on the line, its my little innocent childs. Smith, an Iraq and Afghanistan war vet and NATO medal of honor recipient, gave birth to Haven 100 days early, weighing just nine-tenths of a pound.

Its about the size of coke can, Smith said.

Haven is one of 450,000 babies in the U.S. born prematurely each year. For two-thirds of those deliveries, no one knows why. Mira Moufarrej, a Bioengineering PhD Student at Stanford University said, When people think about what tools an obstetrician has right now to look at a pregnancy, its ultrasound and thats it.

Now bioengineers at Stanford have developed a blood test that detects with 80 percent accuracy who will deliver early. Something that ultrasound cannot do.

Moufarrej explained, it tells you more about whats going on in the process of building a baby and what might go wrong.

The test looks at RNA molecules found in the mothers blood.

Looking at those seven types of RNA molecules, theyre higher in women who deliver preterm than full-term, Moufarrej said.

The team hopes doctors will then be able to start treatments that will delay delivery. Haven spent the first 241 days of his life in the hospital, has had seven surgeries since birth, hes on oxygen and takes 18 syringes of medication daily. But as his mom says, hes a fighter.Smith said to Haven, I get to watch you stand up, smile, and give people hope.

In low-resource settings, a test to predict time to delivery has tremendous potential to impact womens health particularly for disadvantaged women with limited access to hospitals. Because a blood test is cheap and easy to use, it has the potential to complement ultrasound and expand access to good prenatal care. Amanda is documenting little Havens journey. You can follow them both on Facebook at https://m.facebook.com/TeamHavenGreyson/

Contributors to this news report include: Marsha Lewis, Field Producer; Evan Boarders, Videographer; Cyndy McGrath, Supervising Producer; Roque Correa, Editor.

To receive a free weekly e-mail on Medical Breakthroughs from Ivanhoe, sign up at: http://www.ivanhoe.com/ftk

BACKGROUND: When a baby is born more than three weeks earlier than the predicted due date, that baby is called premature. Premature babies (preemies) have not grown and developed as much as they should have before birth. Most of the time, doctors dont know why babies are born early. When they do know, its often because a mother has a health problem during pregnancy, such as diabetes, hypertension, heart or kidney problems, and an infection of the amniotic membranes or vaginal or urinary tracts. Other reasons why a baby may be born early include bleeding, often due to a low-lying placenta or a placenta that separates from the womb, having a womb that isnt shaped normally, carrying more than one baby, being underweight before pregnancy or not gaining enough weight during pregnancy, or mothers who smoke, use drugs, or drink alcohol while pregnant.(Source: https://kidshealth.org/en/parents/preemies.html)

TREATMENT: Predicting a premature baby could help doctors execute treatment options that may delay delivery. Mira Moufarrej, a Bioengineering PhD Student at Stanford University said, They use ultrasound to estimate in the first trimester how long the baby is. And they know that in the first trimester the relationship between the length of the baby now and due date is a linear relationship. Now if you measure the baby in the second trimester or the third trimester, thats not necessarily the case because at that point differences in humans come into play. Moufarrej says there are a few treatments, but they do not work well. You can do progesterone injections during pregnancy. And then if a woman has a short cervix then you can do a cervical circlage. But theres a narrow group of women that fit that scope and who deliver preterm, and they havent been shown to be that effective.(Source: Mira Moufarrej)

NEW TESTS: Moufarrej talked about the blood tests, So we developed two blood tests. The first one predicts gestational age similar to ultrasound, so when a baby will be due, but it does it in the second and the third trimester as opposed to the first. So, for women who live far away from the clinic or women who dont know theyre pregnant until later in life, this serves as a complement and a substitute whereas in the past there was no substitute to ultrasound. The test had so far shown 80 percent accuracy. (Source: Mira Moufarrej)

FOR MORE INFORMATION ON THIS REPORT, PLEASE CONTACT:

Samantha BealDirector, Media and Public Relations650-498-7056SBeal@stanfordchildrens.org

If this story or any other Ivanhoe story has impacted your life or prompted you or someone you knowto seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas at mthomas@ivanhoe.com

Continue reading here:
HealthWatch: Predicting Preemies: Building Healthier Babies - WeAreGreenBay.com

Pain in the Neck – Newswise – Newswise (press release)

Newswise For millions of sufferers, there is nothing more debilitating than chronic back or joint pain. It can feel like a lifetime of misery.

But researchers led by University of Utah bioengineering assistant professor Robby Bowles have discovered a way to curb chronic pain by modulating genes that reduce tissue- and cell-damaging inflammation.

This has applications for many inflammatory-driven diseases, Bowles says. It could be applied for arthritis or to therapeutic cells that are being delivered to inflammatory environments that need to be protected from inflammation.

The teams discovery was published in a new paper this month, CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments, in a special issue of Tissue Engineering. University of Utah bioengineering doctoral student, Niloofar Farhang, co-authored the study, which is a collaborative project between the University of Utah, Duke University and Washington University in St. Louis.

In chronic back pain, for example, slipped or herniated discs are a result of damaged tissue when inflammation causes cells to create molecules that break down tissue. Typically, inflammation is natures way of alerting the immune system to repair tissue or tackle infection. But chronic inflammation can instead lead to tissue degeneration and pain.

Bowles team is using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) system new technology of modifying human genetics to stop cell death and keep the cells from producing molecules that damage tissue and result in chronic pain. But it doesnt do this by editing or replacing genes, which is what CRISPR tools are typically used for. Instead, it modulates the way genes turn on and off in order to protect cells from inflammation and thus breaking down tissue.

So they wont respond to inflammation. It disrupts this chronic inflammation pattern that leads to tissue degeneration and pain, Bowles says. Were not changing what is in your genetic code. Were altering what is expressed. Normally, cells do this themselves, but we are taking engineering control over these cells to tell them what to turn on and turn off.

Now that researchers know they can do this, doctors will be able to modify the genes via an injection directly to the affected area and delay the degeneration of tissue. In the case of back pain, a patient may get a discectomy to remove part of a herniated disc to relieve the pain, but tissue near the spinal cord may continue to breakdown, leading to future pain. This method could stave off additional surgeries by stopping the tissue damage.

The hope is that this stops degeneration in its tracks, and the patient could avoid any future surgeries, Bowles says. But its patient to patient. Some might still need surgery, but it could delay it.

So far, the team has developed a virus that can deliver the gene therapy and has filed a patent on the system. They hope to proceed to human trials after collecting initial data, but Bowles believes it could be about 10 years before this method is used in patients.

Other researchers on the team include University of Utah orthopaedic surgeon Brandon Lawrence, Duke University biomedical engineering associate professor Charles. A. Gersbach, biomedical engineering professor Farshid Guilak and Distinguished Professor Lori A. Setton of Washington University in St. Louis.

This news release and photos may be downloaded from: http://www.unews.utah.edu

See more here:
Pain in the Neck - Newswise - Newswise (press release)

Regenerative Medicine Workshop, Part 21 – Research Horizons

The Regenerative Medicine Workshop at Hilton Head began its third decade with a long and diverse lineup of researchers who presented their latest work on a spacious range of topics, from DNA barcoded technology to strategies to reverse tissue degeneration in rotator cuff injuries.

In other words, the usual dizzying array of up-to-the-minute research from some of the worlds leading scientists and engineers.

But if there was a topical theme to last weeks 21st annual workshop (March 1-4), it was immunology.

The Hilton Head summit has always been a place where you can learn about the great, late breaking innovations in regenerative medicine, says Ned Waller, professor in the Emory University School of Medicine, and a researcher with the Petit Institute for Bioengineering and Bioscience at Georgia Tech. What striking this year is, half the talks are about immunology.

And that suits Waller just fine. He is director of the Division of Stem Cell Transplantation and Immunotherapy at the Winship Cancer Institute of Emory, where he also directs the Bone Marrow and Stem Cell Transplant Center. And his research presentation at Hilton Head was entitled, Another Arrow in the Anti-cancer Quiver: VIP Immunotherapy.

Waller also is one of three co-directors of the Regenerative Engineering and Medicine (REM) research center, a consortium of research institutes in Georgia: Emory, Georgia Tech, and the University of Georgia. REM is one of four organizing partners of the workshop, the others being the Stem Cell and Regenerative Medicine Center at the University of Wisconsin, the Mayo Clinics Center for Regenerative Medicine, and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh.

Accordingly, faculty, post-doctoral, and student researchers from those institutions were well represented. But the workshop also drew researchers from across the spectrum and the planet. Among the speakers were Ronald Germain from the National Institutes of Health, and Molly Stevens from Imperial College in London. Rolando Gittens, who earned his Ph.D. in bioengineering at Georgia Tech in 2012 and is now a research scientist at the Institute for Scientific Research and High Technology Services of Panama.

There were also deep-dive presentations from researchers based at Duke, Harvard, Tufts, and Yale universities, among others, and Jeff Hubbell, the Nerem Lecturer from the University of Chicago (who delivered a talk on Biomolecular Engineering in Regenerative Medicine and Immunotherapies).

Steve Stice, as co-director of the REM from the University of Georgia (UGA), the newest member of the consortium, appreciated the geographic range of work that was presented.

One of the nice things this years is that UGA and other institutions are well represented, says Stice, professor and director of the Regenerative Bioscience Center at UGA and a Petit Institute researcher. So its not just Emory and Georgia Tech, its also Mayo, and Wisconsin, and Pittsburgh, and weve brought in speakers from all over. Its really grown and become a highly recommended event in the regenerative medicine community.

Trainees postdocs, grad students, and at least one undergraduate had a chance to present their work, also. First there was the rapid fire presentations (5 minutes) on Thursday afternoon, then a research poster competition that night, featuring 65 different projects on display.

The winning poster came from Daniel Hachim, a grad student at the University of Pittsburgh, whose project is entitled, Unveiling Macrophage Populations and Mechanisms Driving the Better Remodeling Outcomes Associated with Shifting Phenotype in the Host Response Against Biomaterials.

Cheryl San Emeterio, a Ph.D. student at Georgia Tech, has presented posters the last three years at this event, but this was her first rapid fire presentation.

I thought it was flattering and inspiring, to talk among so many distinguished scientists here, says San Emeterio, who does her research in the lab of Ed Botchwey, associate professor in the Wallace H. Coulter Department of Biomedical Engineering (a joint department of Emory and Georgia Tech).

Its great to get my work out there on this scale, and I hope that people are interested and want to discuss it further. And maybe we can form some sort of productive collaboration, adds San Emeterio, whose research is entitled, Age-dependent immune Dysregulation during Repair of Volumetric Muscle Injury.

Standing near her poster for most of the evening was Madeline Smerchansky, a Petit Undergraduate Scholar from Georgia Tech attending her first Hilton Head conference. She saw the opportunity as something of an investment.

This is practice for the future, says Smerchansky, a third-year student.

At least one researcher during the four-day workshop offered a glimpse into the future from a perspective that did not include biomolecular science or immunology. Aaron Levine offered his insights , but not the usual stuff based in biomolecular science or bioengineering. Aaron Levine, associate professor in the School of Public Policy at Georgia Tech and a Petit Institute researcher, delivered a presentation called, Regenerative Medicine in a Time of Policy Uncertainty.

We havent seen a lot of clear signals yet with how the policy environment is going to play out from the current presidential administration, says Levine, who focused his Friday morning talk on, among other things, potential policy drivers for regenerative medicine, such as the 21st Century Cures Act (will it be implemented by this administration, and if so, how much of it?), and the appointment of a commissioner for the Food and Drug Administration (FDA).

The future of the Cures Act may be largely dependent on who the next FDA commissioner is, noted to Arnie Caplan, of Case Western University, during Levines post-talk Q&A session.

Later that evening, it was Caplans turn to take center stage, with Chris Evans of the Mayo Clinic.

They were the main event, you might say. With a backdrop of Caplan and Evans as photo-enhanced boxers, the mood was light for their Friday night debate, entitled, MSCs are Not Stem Cells. Or, as Nerem put it, is an MSC a mesenchymal stem cells, a medical signaling cell, or a mediocre scientific concept.

By all accounts, they verbally fought to a draw. But who knows. Maybe there will be a rematch in 2018, when the Regenerative Medicine Workshop will return to Hilton Head (March 21-24).

CONTACT:

Jerry Grillo Communications Officer II Parker H. Petit Institute for Bioengineering and Bioscience

More:
Regenerative Medicine Workshop, Part 21 - Research Horizons

Bioengineering test plot in Lions Park – Devon Dispatch

Submitted by Allan Macaulay

You may have noticed the Town of Devons sign in Lions Park recently referring to a bioengineering test plot. Its time to talk about it.

Bioengineering in this context is a process that uses local plant material to stabilize an eroding river or stream bank. If we are satisfied with this process we can apply it to Beaver Loop and other unstable locations around town.

What got this going? This grew out of an environmental plan a group of us did for the Town a few years ago. We started talking and got to know Kristen Anderson a local resident and knowledgeable environmental consultant who now works for Associated Engineering.

Associated Engineering in conjunction with the Town of Devon, Devon Nature Club and Devon Lions Club hosted a two day bioengineering course one day in the classroom at the golf course and one day hands on installing the test plot on the river bank in Lions Park. We used tree stems as the building blocks for the project. The stems were cut on property on the west side of highway 60 with permission of the land owner Qualico Developments. The plant material mostly willow and Balsam poplar was dormant at this time i.e. bud break had not occurred yet. Dormancy and proper handling of the material is key. Its alive and we have to keep it that way. Our instructors were David Polster and Kristen Anderson.

The project was carried out by a group of people including members of the above organizations on April 19 of this year. Several other municipalities and contractors also attended.

Two different methods were used one is called dense live staking at the bottom of the slope and wattle fencing on the slope.

Dense Live Staking

Stakes were cut from balsam poplar and willow. The stakes are 70-100 cm long and 25-50 mm in diameter. We sharpened them and then inserted them into the ground using planting bars and rubber mallets. We tried to get 75 per cent of their length in the ground this is very important. They were placed about 10 cm apart in a random pattern

Wattle Fencing

We then went up the slope installing whats called wattle fencing which consists of more staking in a row these stakes are similar to the ones used in the live staking but they are in a row and about .5 meters apart.

These stakes are used for the support of the fence made of 3-5 m lengths of willow and balsam poplar stems which are about 25-50 mm thick at the base. These long stems are stacked against the live stakes about 6 high and held in place by the natural soils piled against the fence on the upslope side.

These wattle fences were installed 30 cm apart all the way up the slope.

The fence and staking slows runoff down on the slope stabilizing the slope and also holds the bank when the stream or river rises.

All components used in all aspects are living and naturally occurring in this area. Only similar soil from the area is used not bringing in any invasive species or other contaminants. We are taught in the course to only use what is available in the area and natural to the site.

Everything grows and recreates a natural stabilizing process. The project we did was all done by hand.

A beaver proof fence is installed along the river which will have to be maintained from time to time and we are watering the site up to twice a week. There is already lots of growth and its looking good.

Devon participants in the course were, Tanya Hugh, Shawn ONeill, Gord McPherson, Alan Voles, Ted Belke, Shawn Goin, Bill White, Allan Macaulay, Karen Macaulay, Kristin Walsh, plus some other town staff from water treatment plant etc.

We could organize a tour of the site with an explanation if you want contact me Allan Macaulay at albertaspruce@albertatrees.net to set that up.

Read the rest here:
Bioengineering test plot in Lions Park - Devon Dispatch

Now you can build your own bio-bot – ScienceBlog.com (blog)

Ill bet you dont have one of these at home.

For the past several years, researchers at the University of Illinois at Urbana-Champaign have been developing a class of walking bio-bots powered by muscle cells and controlled with electrical and optical pulses. Now, Rashid Bashirs bioengineering research group is sharing the recipe for the current generation of bio-bots. Their how-to paper is the cover article in Nature Protocols.

The protocol teaches every step of building a bio-bot, from 3D printing the skeleton to tissue engineering the skeletal muscle actuator, including manufacturers and part numbers for every single thing we use in the lab, explained Ritu Raman, now a postdoctoral fellow in the Department of Bioengineering and first author of the paper, A modular approach to the design, fabrication, and characterization of muscle-powered biological machines.

This protocol is essentially intended to be a one-stop reference for any scientist around the world who wants to replicate the results we showed in our PNAS 2016 and PNAS 2014 papers, and give them a framework for building their own bio-bots for a variety of applications, Raman said.

As stated in the Nature Protocols paper, Biological machines consisting of cells and biomaterials have the potential to dynamically sense, process, respond, and adapt to environmental signals in real time. This can result in exciting possibilities where these systems could one day demonstrate complex behaviors including self-assembly, self-organization, self-healing, and adaptation of composition and functionality to best suit their environment.

Bashirs group has been a pioneer in designing and building bio-bots, less than a centimeter in size, made of flexible 3D printed hydrogels and living cells. In 2012, the group demonstrated bio-bots that could walk on their own, powered by beating heart cells from rats. However, heart cells constantly contract, denying researchers control over the bots motion.

The purpose of the paper was to provide the detailed recipes and protocols so that others can easily duplicate the work and help to further permeate the idea of building with biologyso that other researchers and educators can have the tools and the knowledge to build these bio-hybrid systems and attempt to address challenges in health, medicine, and environment that we face as a society, stated Rashid Bashir, a Grainger Distinguished Chair in Engineering and head of the Department of Bioengineering.

The 3D printing revolution has given us the tools required to build with biology in this way. Raman said. We re-designed the 3D-printed injection mold to produce skeletal muscle rings that could be manually transferred to any of a wide variety of bio-bot skeletons. These rings were shown to produce passive and active tension forces similar to those generated by muscle strips.

Using optogenetics techniques, we worked with collaborators at MIT to genetically engineer a light-responsive skeletal muscle cell line that could be stimulated to contract by pulses of 470-nm blue light, Raman added. The resultant optogenetic muscle rings were coupled to multi-legged bio-bot skeletons with symmetric geometric designs. Localized stimulation of contraction, rendered possible by the greater spatiotemporal control of light stimuli over electrical stimuli, was used to drive directional locomotion and 2D rotational steering.

In addition to Bashir and Raman, Caroline Cvetkovic, a recent graduate student in bioengineering and now a post-doctoral fellow was a co-author of the paper. Work on the bio-bots was conducted at the Micro + Nanotechnology Lab at Illinois. _____________

Contact: Rashid Bashir, Department of Bioengineering,University of Illinois at Urbana-Champaign, 217/333-1867; rbashir@illinois.edu.

Rick Kubetz, Engineering Communications Office, University of Illinois at Urbana-Champaign, 217/244-7716, rkubetz@illinois.edu.

Here is the original post:
Now you can build your own bio-bot - ScienceBlog.com (blog)

Mushroom Fermenter Market- Bioengineering, Eppendorf, DCI-Biolafitte, Sartorius, Infors HT, Applikon Biotechnology. – Satellite PR News (press…

Submit the press release

Report studies Mushroom Fermenter in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Bioengineering Eppendorf DCI-Biolafitte Sartorius Infors HT Applikon Biotechnology MARUBISHI

The Market Research report Global Mushroom Fermenter Market 2016 by QY Research Group is a market-oriented, technical, and commercial research analysis of the Mushroom Fermenter market. The analysis is completed using a wide range of secondary sources, databases and directories in order to identify and assemble market data. Primary sources included for the analysis include preferred suppliers, industry experts from core and associated industries, manufacturers, service providers, distributors, and organizations allied to the entire segments of the industry supply chain.

To Get Sample Copy of Report visit @ goo.gl/c8l7Wy

To estimate the overall market size of Mushroom Fermenter, its application, and regionsin terms of value and volumethe bottom-up approach is followed. On the other hand, to corroborate the overall Mushroom Fermenter market sizeagain in terms of value and volumethe top-down approach is followed. Following the method of data triangulation and data validation via primaries, the precise values of the parent market and individual market in terms of size are calculated and established in the report.

This market research report provides the client with comprehensive market analysis of the Mushroom Fermenter market over the forecast period. In addition, it also furnishes a general idea of the challenges, drivers, and restraints that have direct or indirect impact on the industry. It further highlights the market, the industry, and latest technology trends currently existing in the Mushroom Fermenter market. All this precise, accurate and comprehensive data will help the clients to make appropriate and practical decisions so as to gain maximum profit in the global market.

Browse Complete Report with TOC @ goo.gl/IKjquj

The research report analyzes, tracks, and presents the global market size of the major players in every region around the world. Furthermore, the report provides data of the leading market players in the Mushroom Fermenter market.

Overall, the report is a one-stop destination and a valuation report to grab all the necessary information regarding the global Mushroom Fermenter market.

About Us:

QYResearch Group is a single destination for all the industry, company and country reports. QYResearch Group also carries the capability to assist you with your customized market research requirements including in-depth market surveys, primary interviews, competitive landscaping, and company profiles. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics. QYResearch Group is the comprehensive collection of market intelligence products and services available on air.

Contact US:

Joel John 3422 SW 15 Street, Suit #8138, Deerfield Beach, Florida 33442, United States Tel: +1-386-310-3803 GMT Tel: +49-322 210 92714 USA/Canada Toll Free No. 1-855-465-4651 Email: sales (@) qyresearchgroup (dot) com

This release was published on openPR.

Continued here:
Mushroom Fermenter Market- Bioengineering, Eppendorf, DCI-Biolafitte, Sartorius, Infors HT, Applikon Biotechnology. - Satellite PR News (press...

College of Engineering and Science | Bioengineering

The Page Morton Hunter Distinguished Seminar Series is held in Rhodes Annex 111 at 3:30 p.m. The C. Dayton Riddle Distinguished Seminar Series is held at CUBEInC at 5:30 p.m. Richard E. Swaja Guest Lectures are held as announced.

2015-2016 Page Morton Hunter Distinguished Seminar Series 09-03-2015Dr. Hitesh Handa, University of Georgia 10-02-2015Dr. David Kaplan, Tufts University at 1:30 p.m. 11-19-2015Dr. Maria Oden, Rice University

2-25-2016Dr. Ayman El-Baz, University of Louisville

3-3-2016Dr. Glen Kwon, University of Wisconsin3-17-2016Dr. David A. Vorp, University of Pittsburgh

4-14-2016Dr. Jeff Karp, Brigham and Women's Hosp. and Harvard4-28-16Dr. Yuehuei An,North Shore-LIJ Orthopaedic Institute at Babylon

2015-2016 C. Dayton Riddle Seminars 12-03-15Dr. Jeff Willey, Wake Forest University

01-21-16Dr. Kirill Afonin, University of North Carolina, Charlotte

3-10-16Jennifer Woodell-May, Zimmer Biomet

3-31-16Eva Mezey, Nat. Inst. of Dental and Craniofacial Research

See the article here:
College of Engineering and Science | Bioengineering

Welcome to Penn State Biomedical Engineering

Welcome to the Penn State Department of Biomedical Engineering (BME). These are exciting times both in the field and our department. I am seeing more innovative and exciting research from Penn State BME than ever before. Combined with the growth our department has seen over the past several years, we truly are broadening the impact of biomedical engineering activities locally, nationally and internationally! At Penn State, BME is the nucleus of interdisciplinary activities in engineering approaches to the medical and life sciences at the University, from the College of Engineering, Medicine, Science, the Huck Institutes of the Life Sciences, Materials Research Institute, and the Institute for CyberScience.

The Department of BME administers the undergraduate major, offering a B.S. degree, and is part of the College of Engineering. The graduate program in the Department of BME, offering a M.S., Ph.D. and M.D.-Ph.D., is a part of the university-wide Intercollege Graduate Degree Program in Bioengineering, which is made up of BME faculty and faculty from a wide variety of other disciplines.

Whether you are a looking for an undergraduate degree, graduate degree, postdoc or a business needing collaboration, our department is uniquely suited to work with you. Thank you for reaching out to us and feel free to contact us with your questions or needs.

Read more:
Welcome to Penn State Biomedical Engineering

Home – U of U Biomedical Engineering

Sticky. Stretchy. Waterproof. Next-Gen Bioadhesives. -Watch a video that shows how silk from caddisfly larvae known to western fly fishermen as 'rock rollers' is one of the inspirations in nature that Professor Stewart's lab is using in their search for dramatically improved medical bioadhesives.Article and video Bioengineering Ph.D Candidate Wins B2B Grand Prize -Spencer Madsen won the $15,000 grand prize in the Bench-to-Bedside competition with PlusOne Baby, a wireless, no-contact monitor that allows parents to keep tabs on their childrens respirations with no strings attached.More information ... Bioengineering Students Win Entrepreneur Challenge Grand Prize. -Bioengineering students Benjamin Fogg and Samer Merchant were on the team that won first place and the $40,000 grand prize at the annual Utah Entrepreneur Challenge for their design of a new endotracheal tube.More information ... Assistant Professor Tara L. Deans Receives Prestigious NSF Career Award. -Deans work in "synthetic biology could give wounded soldiers, and anyone who suffers massive trauma, the ability to stop their own bleeding, saving their life. The five-year grant is for more than $500,000.More... Validating Simulation Pipelines with Potential Recordings -Ph.D. Research Proposal by Jess Tate, Tuesday October 4, 3:00 pm, WEB 2760 - Meldrum conference room Read More... Micro Engineering for Macro Impacts: Toward Personalized Assessment of Environmental Impacts -Presented by Hanseup Kim, Wednesday October 5, 11:50 am, 2250 WEBRead More... Spectroscopic histology of the superior vena cava and right atrium: A method for accurately placing PICCs at the cavoatrial junction -Ph.D. Research Proposal by Bradley James Stringer, Thursday October 6, 4:00 pm, University of Utah School of Medicine, 30 N 1900 E, Room 3C444Read More... Bioengineering Program Ranked No.2 by Students - Again! -For the second time in a year, the University of Utahs Department of Bioengineering graduate program was ranked second in the nation, according to a survey of studentsMore Information...

More here:
Home - U of U Biomedical Engineering

Biotechnology and Bioengineering News — ScienceDaily

Regulatory, Certification Systems Creating Paralysis in Use of Genetically Altered Trees Aug. 20, 2015 Myriad regulations and certification requirements around the world are making it virtually impossible to use genetically engineered trees to combat catastrophic forest threats, according to a new ... read more Aug. 14, 2015 Another barrier to commercially viable biofuels from sources other than corn has fallen with the engineering of a microbe that improves isobutanol yields by a factor of ... read more New Information Changes Few Opinions on GMOs, Global Warming June 2, 2015 First impressions are critical. So much so that for many people, even when they are given scientific information, they won't change their minds. This is particularly true for issues such as ... read more May 29, 2015 The roots of a plant are constantly growing, so that they can provide the plant with water and minerals while also giving it a firm anchor in the ground. Responsible for these functions are ... read more Scientists See a Natural Place for 'Rewilded' Plants in Organic Farming May 28, 2015 One key element of organic agriculture is that it rejects unpredictable technologies, such as genetic engineering. But what if adding a gene from undomesticated plants to bring back a natural trait ... read more May 4, 2015 Is there a sixth DNA base? A team of researchers suggests that the methyl-adenine that would regulate the expression of certain genes in eukaryotic cells could have a specific role in stem cells and ... read more Apr. 30, 2015 Researchers have perfected a noninvasive "chemogenetic" technique that allows them to switch off a specific behavior in mice -- such as voracious eating -- and then switch it back on. The ... read more Apr. 24, 2015 Stem cells naturally cling to feeder cells as they grow in petri dishes. Scientists have thought for years that this attachment occurs because feeder cells serve as a support system, providing stems ... read more Apr. 24, 2015 Researchers have discovered that the signalling route - a cascade activation of several molecules - triggered by the ATM protein regulates DNA repair during the production of spermatocytes by ... read more Apr. 21, 2015 Sweet potatoes from all over the world naturally contain genes from the bacterium Agrobacterium, researchers report. Sweet potato is one of the most important food crops for human consumption in the ... read more Bioenergy: Genetics of Wood Formation Apr. 17, 2015 To begin to understand poplar growth, a possible bioenergy crop, scientists built a robust high-throughput pipeline for studying the hierarchy of genetic regulation of wood formation using ... read more Apr. 6, 2015 Researchers have developed a new method to activate genes by synthetically creating a key component of the epigenome that controls how our genes are expressed. The new technology allows researchers ... read more Mar. 24, 2015 Researchers use metabolic engineering and directed evolution to develop a new, mutant yeast strain that could lead to a more efficient biofuel production ... read more Mar. 16, 2015 Consumers were willing to spend more for biotech potato products with reduced levels of a chemical compound linked to cancer, a study has found. The findings underscore the importance of efforts to ... read more Jailbreaking Yeast Could Amp Up Wine's Health Benefits, Reduce Morning-After Headaches Mar. 16, 2015 A 'jailbreaking' yeast has been developed that could greatly increase the health benefits of wine while reducing the toxic byproducts that cause your morning-after ... read more Enhancing High-Temperature Tolerance in Plants: Effective on Rice and Tomatoes Mar. 2, 2015 Agricultural researchers have identified for the first time that theE-2-hexenal, a plant-derived chemical substance, can induce a plant's stress response to high ... read more Feb. 25, 2015 A survey of rice, wheat, barley, fruit, and vegetable crops found that most mutants created by advanced genetic engineering techniques may be out of the scope of current genetically modified organism ... read more Feb. 24, 2015 Scientists have generated mature, functional skeletal muscles in mice using a new approach for tissue engineering. The scientists grew a leg muscle starting from engineered cells cultured in a dish ... read more Gene May Help Reduce GM Contamination Feb. 19, 2015 Genetically modified crops have long drawn fire from opponents worried about potential contamination of conventional crops and other plants. Now a plant gene might help farmers reduce the risk of GM ... read more Feb. 9, 2015 Researchers have demonstrated a new way to activate genes with light, allowing precisely controlled and targeted genetic studies and applications. The method might be used to activate genes in a ... read more

Thursday, August 20, 2015

Friday, August 14, 2015

Tuesday, June 2, 2015

Friday, May 29, 2015

Thursday, May 28, 2015

Monday, May 4, 2015

Thursday, April 30, 2015

Friday, April 24, 2015

Tuesday, April 21, 2015

Friday, April 17, 2015

Monday, April 6, 2015

Tuesday, March 24, 2015

Monday, March 16, 2015

Monday, March 2, 2015

Wednesday, February 25, 2015

Tuesday, February 24, 2015

Thursday, February 19, 2015

Monday, February 9, 2015

Thursday, February 5, 2015

Wednesday, February 4, 2015

Monday, February 2, 2015

Wednesday, January 28, 2015

Wednesday, January 21, 2015

Tuesday, January 13, 2015

Tuesday, December 16, 2014

Monday, December 15, 2014

Monday, December 1, 2014

Monday, November 24, 2014

Tuesday, November 11, 2014

Thursday, November 6, 2014

Monday, November 3, 2014

Thursday, October 30, 2014

Wednesday, October 29, 2014

Thursday, October 23, 2014

Tuesday, October 21, 2014

Sunday, October 19, 2014

Friday, October 17, 2014

Tuesday, October 14, 2014

Monday, October 13, 2014

Thursday, October 2, 2014

Friday, September 26, 2014

Tuesday, September 23, 2014

Sunday, September 21, 2014

Wednesday, September 17, 2014

Tuesday, September 9, 2014

Wednesday, September 3, 2014

Tuesday, August 12, 2014

Wednesday, August 13, 2014

Sunday, August 10, 2014

Wednesday, August 6, 2014

Monday, August 4, 2014

Tuesday, July 29, 2014

Monday, July 14, 2014

Thursday, July 10, 2014

Thursday, July 3, 2014

Monday, June 30, 2014

Thursday, June 26, 2014

Tuesday, June 24, 2014

Thursday, June 19, 2014

Wednesday, June 11, 2014

Monday, June 9, 2014

Thursday, June 5, 2014

Wednesday, June 4, 2014

Monday, June 2, 2014

Thursday, May 29, 2014

Wednesday, May 28, 2014

Monday, May 26, 2014

Thursday, May 15, 2014

Tuesday, May 13, 2014

Monday, May 12, 2014

Sunday, May 4, 2014

Wednesday, April 30, 2014

Tuesday, April 15, 2014

Thursday, April 10, 2014

Tuesday, April 8, 2014

Friday, April 4, 2014

Thursday, April 3, 2014

Thursday, March 27, 2014

Wednesday, March 26, 2014

Thursday, March 20, 2014

Tuesday, March 18, 2014

Monday, March 17, 2014

Sunday, March 16, 2014

Thursday, March 13, 2014

Monday, March 10, 2014

Sunday, March 9, 2014

Wednesday, March 5, 2014

Tuesday, March 4, 2014

Thursday, February 27, 2014

Read more:
Biotechnology and Bioengineering News -- ScienceDaily

SSOE – Bioengineering

Bioengineering, Chemical & Petroleum

PITTSBURGH (July 16, 2015) Steven Little , Associate Professor, CNG Faculty Fellow and Chair of the Department of Chemical and Petroleum Engineering at the University of Pittsburgh's Swanson School of Engineering, has been elected a Class of 2015 Fellow of the Biomedical Engineering Society (BMES) . Founded in 1968, BMES is an interdisciplinary professional society for biomedical engineering and bioengineering. Fellow status is awarded to Society members who demonstrate exceptional achievements and experience in the field of biomedical engineering, and a record of membership and participation in the Society. Dr. Little holds eight US patents and provisional applications for patents including new methods to fabricate controlled release vehicles in a high throughput fashion; dissolvable synthetic-vasculature; novel complex delivery vehicles; and a description of the first degradable, artificial cell. He has authored/co-authored 70 articles in highly prestigious archival journals in his fields of specialization (controlled release, biomimetic materials, tissue engineering/regenerative medicine and drug delivery). "Dr. Little's election as BMES Fellow recognizes his seminal contributions to bioengineering education and research during his academic career," noted Harvey Borovetz , Distinguished Professor and Former Chair of Bioengineering and the Robert L. Hardesty Professor of Surgery at Pitt, and BMES Fellow who nominated Dr. Little. "In addition to his remarkable achievements in his research, Dr. Little is a prolific classroom instructor whose courses are among the most highly rated in the Swanson School of Engineering. He is the mentor for numerous M.S. and Ph.D. candidates; his lab is a magnet for undergraduate students, with more than 40 undergraduate interns being mentored by Dr. Little to date. We are very proud to recognize Dr. Steven Little as a Class of 2015 Fellow of the Biomedical Engineering Society." Dr. Little joins the ranks of several BMES Fellows at Pitt, including Dr. Borovetz; Clifford Brubaker , Distinguished Service Professor and Dean Emeritus of the School of Health and Rehabilitation Sciences; Rory Cooper , FISA/PVA Endowed Chair and Distinguished Professor of the Department of Rehabilitation Science and Technology, School of Health and Rehabilitation Sciences; William Federspiel , the William Kepler Whiteford Professor of Bioengineering; Sanjeev Shroff, Distinguished Professor and the Gerald E. McGinnis Chair in Bioengineering and Professor of Medicine; David Vorp , Associate Dean for Research in the Swanson School of Engineering and the William Kepler Whiteford Professor of Bioengineering; William Wagner , Director of the McGowan Institute for Regenerative Medicine and Professor of Surgery, Bioengineering and Chemical Engineering; and Savio L-Y. Woo , Distinguished University Professor of Bioengineering and the Founder and Director of the Musculoskeletal Research Center (MSRC). More About Dr. Little Dr. Steven Little is Associate Professor of Chemical Engineering, Bioengineering, Immunology, Ophthalmology and The McGowan Institute for Regenerative Medicine at the University of Pittsburgh. He is a University Honors College Faculty Fellow. Dr. Little received his PhD in Chemical Engineering from MIT in 2005, with his thesis winning the American Association for Advancement of Science's Excellence in Research Award. In May of 2012, Dr. Little was appointed as the 12th Chairman of the Department of Chemical & Petroleum Engineering, one of the oldest Departments of its type in the world, dating back to 1910. In his first year on the Pitt faculty (2006), Dr. Little was appointed as a Distinguished Faculty Fellow in Engineering, the only Assistant Professor to hold this position. In 2007, he received career development awards from both the American Heart Association and the National Institutes of Health (K-Award). In 2008, Dr. Little was named as one of only 16 Beckman Young Investigators by the Arnold & Mabel Beckman Foundation. Dr. Little is the only individual from the University of Pittsburgh to have ever received this award. In 2009, he was presented with the Board of Visitors Award that denotes the "single most outstanding faculty member in the School of Engineering." In 2010, he received the Coulter Translational Research Award from the Wallace H. Coulter Foundation. In 2011, Dr. Little was named the recipient of the Society For Biomaterials' Young Investigator Award. In 2012, Dr. Little received the University of Pittsburgh's Chancellor's Distinguished Research Award, and by winning the 2013 Chancellor's Distinguished Teaching Award, Dr. Little stands as the only professor in School history to receive both the teaching and research awards. Dr. Little was also named as one of only 14 "Camille Dreyfus Teacher-Scholars" by the Camille & Henry Dreyfus Foundation in 2013 and also was named the recipient of the Carnegie Science Award for University Educators that year. In 2014, Dr. Little was named the winner of the Research to Prevent Blindness Innovative Ophthalmic Research Award, the recipient of a Phase II Coulter Translational Award, named one of Pittsburgh Magazine's "40 under 40," and highlighted as one of only five individuals in Pittsburgh who are "reshaping our world" by Pop City Media. In 2015, Dr. Little was named the winner of the Carnegie Science Award for Advanced Materials, a Fast Tracker (University Leader category) by the Pittsburgh Business Times, a Fellow of the Biomedical Engineering Society (BMES), and the winner of the 2015 Curtis W. McGraw Award from the American Society for Engineering Education (ASEE). Dr. Little is also a Co-Founder of Qrono Inc. , which is a Pittsburgh-based start-up company that provides custom designed controlled release formulations for pharmaceutical companies, agricultural industry, and academic laboratories. About the Department of Chemical and Petroleum Engineering The Swanson School's Department of Chemical and Petroleum Engineering serves undergraduate and graduate engineering students, the University and industry, through education, research, and participation in professional organizations and regional/national initiatives. The Department maintains a tradition of excellence in education and research, evidenced by recent national awards including numerous NSF CAREER Awards, a Beckman Young Investigator Award, an NIH Director's New Innovator Award, and the DOE Hydrogen Program R&D Award, among others. Active areas of research in the Department include Biological and Biomedical Systems; Energy and Sustainability; and Materials Modeling and Design. The faculty holds a record of success in obtaining research funding such that the Department ranks within the top 25 U.S. Chemical Engineering departments for Federal R&D spending in recent years with annual research expenditures exceeding $7 million. The vibrant research culture within the Department includes active collaboration with the University of Pittsburgh Medical Center, the Center for Simulation and Modeling, the McGowan Institute for Regenerative Medicine, the Mascaro Center for Sustainable Innovation, the Petersen Institute of NanoScience and Engineering and the U.S. DOE-affiliated Institute for Advanced Energy Solutions. ### Paul Kovach

Read more:
SSOE - Bioengineering

Demystifying Medicine 2015 – Malaria: Bioengineering and the Global Epidemic of a Killer – Video


Demystifying Medicine 2015 - Malaria: Bioengineering and the Global Epidemic of a Killer
Demystifying Medicine 2015 - Malaria: Bioengineering and the Global Epidemic of a Killer Air date: Tuesday, March 03, 2015, 4:00:00 PM Category: Demystifying Medicine Runtime: 01:59:55 ...

By: nihvcast

Continued here:
Demystifying Medicine 2015 - Malaria: Bioengineering and the Global Epidemic of a Killer - Video

Bioengineering and Nanotechnology: Preventing Antibiotics Restistant Microbes – Video


Bioengineering and Nanotechnology: Preventing Antibiotics Restistant Microbes
Speaker: Dr. James L. Hedrick, Research Staff Member, IBM Almaden Research Center, San Jose, CA CLINAM 7/ 2014, 7th Conference and Exhibition, June 23-25, 2014.

By: TAUVOD

Go here to read the rest:
Bioengineering and Nanotechnology: Preventing Antibiotics Restistant Microbes - Video

IIT Madras Hosts International convention on ‘Synthetic Biology’ – India Today

Indian Institute of Technology Madras is hosting the India-EMBO Symposium on 'Engineering meets evolution: Designing biological systems' from 30th January to 1st February 2020. The event brought together leading scientists, researchers, and first-stage research scholars to discuss the advances and latest research findings in the field of 'Synthetic Biology' and 'Bioengineering'.

It is jointly organised by Initiative for Biological Systems Engineering (IBSE), IIT Madras, and the European Molecular Biology Organization (EMBO).

The aim of the India-EMBO symposium is to provide a platform to the research community for exchanging ideas, discussing challenges encountered and sharing research experiences. It focused on various aspects of bioengineering and synthetic biology, such as:

The India-EMBO symposium will help to identify the research opportunities and priorities in bioengineering and synthetic biology. The perspective of speakers over the three days from different sectors will explain the possible future scope in this field and provide information about the funding availability and ethical considerations to ensure that the research on synthetic biology will be carried out responsibly to realise its full potential.

The interaction sessions between the research scholars and the leading scientists will benefit in promoting collaborations, analysing the bottlenecks in the research fields, and the possible innovative solutions to overcome the challenges. On a concluding note, this symposium will be a potential platform that elicits confidence among research scholars to establish their career in synthetic biology.

Delivering the Keynote address on 'thinking big: engineering SynBio interventions on a global scale,'"The environmental microbiome once improved and reprogrammed with the tools of synthetic biology, can become our main ally to fight climate change," said, Dr. Victor de Lorenzo, Group Leader, Molecular Environmental Microbiology Laboratory, National Centre for Biotechnology (CNB), Spain

About EMBO:

EMBO is an organisation that comprises 1,800 active leading researchers who support excellence in life sciences. The primary goals of EMBO are to endorse talented researchers, aid in building a better research environment, and promote the exchange of scientific ideas and information.

Several contributions through short courses, workshops, conferences, and press publications support EMBO to maintain high standards of excellence in research practice.

About IIT Madras:

IIT Madras has been designated as one of the premier centres for basic and applied research, technical education, and industrial collaborations in India. The internationally recognised faculties, talented student's pool, and intensive research contribute to achieving the pre-eminent status of IIT Madras. IIT Madras houses 16 departments and a few advanced research centres in various disciplines.

About IBSE:

IBSE is an interdisciplinary group that works on developing innovative methodologies to integrate multi-omics data to understand, predict, and manipulate complex biological systems.

The research undertaken at IBSE includes the study of gene-gene and gene-host interactions in order to unravel the genotype to phenotype map that facilitates adaptation in yeast and the study of design principles for building synthetic biological parts. The students at IITM have been active participants at the International Genetically Engineered Machine (iGEM) competition, which is a premier competition for building synthetic biological parts.

Read: IIT Bombay bans 'anti-national' activities on Powai campus

Also Read: From ITI to IIT Gandhinagar: 10 students from ITIs become part of MACOM at IITGN

Excerpt from:
IIT Madras Hosts International convention on 'Synthetic Biology' - India Today

Fumaric Acid Market 2020 by Top Manufactures, Drivers, Challenges, Segment Applications, and Forecast 2026 – Bulletin 99

Fumaric Acid Market 2020

Market OverviewA global market is a large sector with several regions competing against each other for a huge chunk of the market share. In a market that has been existing for several years and having several prominent players, new entrants entering the market must first understand whether they can survive there. An extensive study was conducted to understand the global Fumaric Acid market and where each key player stands. Several factors were taken into consideration before the study. The key players, investment, and their revenue share over the years were also considered for the study. More focus was given to product positioning, product sales, product revenue and product category to effectively understand the Fumaric Acid market.

The effectiveness of the marketing strategies adopted by key players were also considered for the study. The marketing strategies were considered to understand whether the changing market, fluctuation in demand and supply, introduction of technology and other factors had any effect on the marketing strategies. The forecast for the Fumaric Acid market shows a steady growth for the years to come.

The top players covered in report are: Yantai Hengyuan Bioengineering, Bartek Ingredients, Polynt, Thirumalai Chemical, Isegen, Fuso Chemicals, Jiangsu Jiecheng Bioengineering, Changzhou Yabang Chemical, NIPPON SHOKUBAI, Sealong Biotechnology, Changmao Biochemical Engineering, Suzhou Youhe Science and Technology, XST Biological

Market Segmentation:The global Fumaric Acid market was segmented into key players in the market, product type, materials used, end users, product application, and geography for the purpose of the study. The key players were further segmented into global, regional and country-level players, their revenue, and market share. It was important to segment the Fumaric Acid market based on their market share to understand the fluctuations that are affecting individual companies. It was found that there were several external factors that influenced a companys market share globally, and regionally.

Fumaric Acid Market Segment by Type: Food-Grade, Technical-Grade

Fumaric Acid Market Segment by Application: Food & Beverages, Rosin Paper Sizes, Unsaturated Polyester Resin, Alkyd Resinss

Regional Analysis:On the basis of region, the global Fumaric Acid market was segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The Americas was once the market leader with a major share of the market. Owing to high demand for the products and services of Fumaric Acid market, the global Fumaric Acid market is presently dominated by UK, and France in Europe. Europe had the largest part of the market share followed by China, India, Japan and the rest of Asia Pacific. The study showed that the drastic change in the increased market share of Europe and Asia Pacific is due to the increased investment in technology and infrastructure.

Drivers and Risks:The increased cost of materials, lack of standardization, limitation of product size, limited process control, and government policies may hinder the growth of global Fumaric Acid market in the years to come. Thought competitive market offers a lot of scope for growth, increased cost of production is a factor that is driving away new entrants and investment. But as several key players are willing to invest in technology, the chances of loss are reduced drastically.

Research Methodology:For the purpose of the study, we used the BCG matrix to understand the market growth-share. The BC matrix helped to understand the growth opportunities for Fumaric Acid Market for the years to come. It also helped formulate strategic planning for the forecast period and showed where investment must be made. The study revealed that even with increase in production cost, there is a potential for growth in the market share even for new entrants who embrace technology.

Request For Customization @https://www.qyresearch.com/customize-request/form/718390/global-fumaric-acid-industry-research-report-growth-trends-and-competitive-analysis-2018-2025

Table of Contents Analysis of Key Points

1 Market Overview

2 Manufacturers Profiles

3 Global Fumaric Acid MarketSales, Revenue, Market Share and Competition by Manufacturer (2018-2019)

4 Global Fumaric Acid Market Analysis by Regions

5 North America Fumaric Acid Market by Country

6 Europe Fumaric Acid Market by Country

7 Asia-Pacific Fumaric AcidMarket by Country

8 South America Fumaric AcidMarket by Country

9 Middle East and Africa Fumaric AcidMarket by Countries

10 Fumaric Acid Market Forecast (2020-2026)

11 Sales Channel, Distributors, Traders and Dealers

12 Research Findings and Conclusion

13 Appendix

List of Tables and Figures

Continued..

Get PDF template of this report:https://www.qyresearch.com/sample-form/form/718390/global-fumaric-acid-industry-research-report-growth-trends-and-competitive-analysis-2018-2025

More:
Fumaric Acid Market 2020 by Top Manufactures, Drivers, Challenges, Segment Applications, and Forecast 2026 - Bulletin 99